Back to Search Start Over

How should we proceed with disease-modifying treatments for multiple sclerosis?

Authors :
Andersson, Peter-Brian
Waubant, Emmanuelle
Source :
Lancet. 3/1/1997, Vol. 349 Issue 9052, p586. 2p. 1 Chart.
Publication Year :
1997

Abstract

Opinion. Argues that time will bring with it greater and greater advances in the development of new disease-modifying therapies for multiple sclerosis (MS). Evidence to suggest a genetic cause for MS; Disease-modifying therapies for MS; Question of what the future holds.

Details

Language :
English
ISSN :
01406736
Volume :
349
Issue :
9052
Database :
Academic Search Index
Journal :
Lancet
Publication Type :
Academic Journal
Accession number :
9703103007
Full Text :
https://doi.org/10.1016/S0140-6736(05)61562-0